ENTRESTO SPRINKLE 15-16 MG PLT

Sacubitril and Valsartan
$11.6233per EA
High Outlier

Strength

15; 16 mg/1; mg/1

NDC

00078123820

Classification

Brand

Dosage Form

PELLET

Route

ORAL

Last Updated

1/7/2026

Active Ingredients

SACUBITRIL; VALSARTAN

Approval Type

New Drug (NDA)

FDA Application

NDA218591

On Market Since

4/12/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Neprilysin Inhibitor
Neprilysin Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

+3.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.